logo
Sign in

GLABF Stock Price, Chart, Stats & News

Gemina Laboratories Ltd.
Save

Gemina Laboratories Ltd. (GLABF) does not currently pay a dividend.

3.83M
Market cap
Current P/E
Forward P/E

GLABF chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections.

Similar securities

Based on sector and market capitalization

Report issue